Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cerebrovascular Moyamoya Disease

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, C1
Ling, C1
Gong, J1
Li, C1
Zhang, L1
Gao, S1
Li, Z1
Huang, T1
Wang, H1
Guo, Y1
Ohkubo, K1
Sakai, Y1
Inoue, H1
Akamine, S1
Ishizaki, Y1
Matsushita, Y1
Sanefuji, M1
Torisu, H1
Ihara, K1
Sardiello, M1
Hara, T1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cerebrovascular Moyamoya Disease

ArticleYear
Increasing the expression of microRNA-126-5p in the temporal muscle can promote angiogenesis in the chronically ischemic brains of rats subjected to two-vessel occlusion plus encephalo-myo-synangiosis.
    Aging, 2020, 07-09, Volume: 12, Issue:13

    Topics: Adult; Animals; Brain; Brain Ischemia; Cell Proliferation; Cerebrovascular Circulation; Chromones; C

2020
Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
    Scientific reports, 2015, Aug-17, Volume: 5

    Topics: Adenosine Triphosphatases; Animals; Cell Line; Cell Proliferation; Chromones; Down-Regulation; eIF-2

2015